Prostate-Specific Membrane Antigen Retargeted Measles Virotherapy for the Treatment of Prostate Cancer

被引:56
作者
Liu, Chunsheng [1 ]
Hasegawa, Kosei [1 ]
Russell, Stephen J. [1 ]
Sadelain, Michel [2 ]
Peng, Kah-Whye [1 ]
机构
[1] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
oncolytic measles virus; PSMA targeting; radiation; prostate cancer; ONCOLYTIC VIRUSES; MONOCLONAL-ANTIBODIES; EXPRESSION; THERAPY; TUMOR; TROPISM; CELLS; ADENOCARCINOMA; CD46;
D O I
10.1002/pros.20962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Live attenuated vaccine strain of measles virus (MV) has promising antitumor activity and is undergoing clinical testing in three different phase I cancer trials. The virus uses one of two receptors, CD46 which is ubiquitously expressed on all nucleated cells or CD150 which is expressed on immune cells, to infect cells. To minimize potential toxicity due to indiscriminate infection of normal cells, we have generated a fully retargeted MV that infects cells exclusively through the prostate-specific membrane antigen (PSMA) receptor, which is overexpressed on prostate cancer cells and tumor neovasculature. METHODS. A single-chain antibody (scFv) specific for the extracellular domain of PSMA (J591) was inserted as a C-terminal extension on the MV attachment protein. Specificity of infection by the PSMA targeted virus was evaluated in parallel with the parental MV and a control virus which binds to CD38, a myeloma antigen. Antitumor activity of the PSMA retargeted virus was tested in both LNCaP and PC3-PSMA tumor xenograft models, with and without low dose external beam radiation. RESULTS. Replication of the PSMA targeted virus was comparable to the parental MV. The PSMA scFv efficiently redirected virus infection and cytopathic killing exclusively to PSMA positive prostate cancer cells and not PSMA negative cells. There was an additive effect on cell killing from radiation treatment and virotherapy. The PSMA virus induced tumor regression of LNCaP and PC3-PSMA tumor xenografts. Extensive areas of MV infection and apoptosis were seen in virus treated tumors. CONCLUSIONS. The PSMA retargeted virus warrants further investigation as a virotherapy agent. Prostate 69: 1128-1141, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:1128 / 1141
页数:14
相关论文
共 56 条
[1]   Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma [J].
Blechacz, Boris ;
Splinter, Patrick L. ;
Greiner, Suzanne ;
Myers, Rae ;
Peng, Kah-Whye ;
Federspiel, Mark J. ;
Russell, Stephen J. ;
LaRusso, Nicholas F. .
HEPATOLOGY, 2006, 44 (06) :1465-1477
[2]   Surgical management of high risk prostate cancer: The Mayo Clinic experience [J].
Boorjian, Stephen A. ;
Blute, Michael L. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) :530-532
[3]  
Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO
[4]  
2-S
[5]   Coating of adeno-associated virus with reactive polymers can ablate virus tropsim, enable retargeting and provide resistance to neutralising antisera [J].
Carlisle, Robert C. ;
Benjamin, Reuben ;
Briggs, Simon S. ;
Sumner-Jones, Stephanie ;
McIntosh, Jenny ;
Gill, Deborah ;
Hyde, Steve ;
Nathwani, Amit ;
Subr, Vladimir ;
Ulbrich, Karel ;
Seymour, Leonard W. ;
Fisher, Kerry D. .
JOURNAL OF GENE MEDICINE, 2008, 10 (04) :400-411
[6]  
Chang SS, 1999, CANCER RES, V59, P3192
[7]   Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter [J].
Dingli, D ;
Peng, KW ;
Harvey, ME ;
Greipp, PR ;
O'Connor, MK ;
Cattaneo, R ;
Morris, JC ;
Russell, SJ .
BLOOD, 2004, 103 (05) :1641-1646
[8]   Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors [J].
Fishelson, Z ;
Donin, N ;
Zell, S ;
Schultz, S ;
Kirschfink, M .
MOLECULAR IMMUNOLOGY, 2003, 40 (2-4) :109-123
[9]   Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins [J].
Frecha, Cecilia ;
Costa, Caroline ;
Negre, Didier ;
Gauthier, Emmanuel ;
Russell, Stephen J. ;
Cosset, Francois-Loic ;
Verhoeyen, Els .
BLOOD, 2008, 112 (13) :4843-4852
[10]   Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses [J].
Fulci, Giulia ;
Breymann, Laura ;
Gianni, Davide ;
Kurozomi, Kazuhiko ;
Rhee, Sarah S. ;
Yu, Jianhua ;
Kaur, Balveen ;
Louis, David N. ;
Weissleder, Ralph ;
Caligiuri, Michael A. ;
Chiocca, E. Antonio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (34) :12873-12878